Details for: PDLIM2

Gene ID: 64236

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: PDLIM2

Ensembl ID: ENSG00000120913

Description: PDZ and LIM domain 2

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • intestinal epithelial cell CL0002563
    CSI 27.3
    rCSI 28.53%
    PRS 68.82
  • skin fibroblast CL0002620
    CSI 20.16
    rCSI 17.38%
    PRS 74.45
  • microcirculation associated smooth muscle cell CL0008035
    CSI 15.98
    rCSI 46.26%
    PRS 71.63
  • syncytiotrophoblast cell CL0000525
    CSI 15.92
    rCSI 45.86%
    PRS 81.37
  • placental villous trophoblast CL2000060
    CSI 13.75
    rCSI 21.25%
    PRS 69.96
  • endothelial cell of lymphatic vessel CL0002138
    CSI 13.45
    rCSI 26.66%
    PRS 80.89
  • perivascular cell CL4033054
    CSI 12.69
    rCSI 17.34%
    PRS 76.68
  • podocyte CL0000653
    CSI 11.81
    rCSI 52.48%
    PRS 71.47
  • fibroblast of lung CL0002553
    CSI 11.69
    rCSI 10.88%
    PRS 71.97
  • epithelial cell of lung CL0000082
    CSI 11.66
    rCSI 9.67%
    PRS 71.27
  • mononuclear phagocyte CL0000113
    CSI 10.58
    rCSI 23.28%
    PRS 75.37
  • bronchus fibroblast of lung CL2000093
    CSI 10.26
    rCSI 8.34%
    PRS 71.27
  • squamous epithelial cell CL0000076
    CSI 9.62
    rCSI 22.83%
    PRS 73.35
  • pancreatic stellate cell CL0002410
    CSI 8.68
    rCSI 50.52%
    PRS 77.74
  • mature B cell CL0000785
    CSI 8.05
    rCSI 7%
    PRS 81.54
  • intermediate monocyte CL0002393
    CSI 7.94
    rCSI 11.98%
    PRS 76.34
  • type B pancreatic cell CL0000169
    CSI 7.8
    rCSI 17.27%
    PRS 69.81
  • memory T cell CL0000813
    CSI 7.27
    rCSI 14%
    PRS 91.97
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 7.12
    rCSI 20.42%
    PRS 89.02
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 6.61
    rCSI 6.02%
    PRS 84.49
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 6.51
    rCSI 8.53%
    PRS 83.51
  • M cell of gut CL0000682
    CSI 5.82
    rCSI 6.19%
    PRS 78.62
  • fallopian tube secretory epithelial cell CL4030006
    CSI 5.81
    rCSI 5.6%
    PRS 70.7
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 5.8
    rCSI 4.41%
    PRS 83.91
  • lung pericyte CL0009089
    CSI 5.48
    rCSI 14.47%
    PRS 79.52
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 5.35
    rCSI 3.56%
    PRS 86.79
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 5.1
    rCSI 5.01%
    PRS 85.7
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 5.06
    rCSI 6.89%
    PRS 91.26
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 4.91
    rCSI 2.9%
    PRS 87.25
  • blood vessel endothelial cell CL0000071
    CSI 4.72
    rCSI 9.8%
    PRS 68.14
  • T-helper 17 cell CL0000899
    CSI 4.67
    rCSI 3.7%
    PRS 90.01
  • double negative thymocyte CL0002489
    CSI 4.57
    rCSI 3.18%
    PRS 82.61
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 4.5
    rCSI 3.6%
    PRS 88.04
  • non-classical monocyte CL0000875
    CSI 4.34
    rCSI 6.95%
    PRS 86.96
  • CD14-positive monocyte CL0001054
    CSI 4.26
    rCSI 5.31%
    PRS 81.58
  • smooth muscle cell CL0000192
    CSI 4.07
    rCSI 9.7%
    PRS 71.11
  • pro-B cell CL0000826
    CSI 4.03
    rCSI 3.34%
    PRS 73.54
  • pulmonary alveolar type 1 cell CL0002062
    CSI 3.96
    rCSI 22.83%
    PRS 68.85
  • fibroblast of breast CL4006000
    CSI 3.8
    rCSI 15.99%
    PRS 79.88
  • myofibroblast cell CL0000186
    CSI 3.77
    rCSI 5.23%
    PRS 70.34
  • enterocyte CL0000584
    CSI 3.65
    rCSI 5.89%
    PRS 72.36
  • precursor B cell CL0000817
    CSI 3.6
    rCSI 3.16%
    PRS 79.62
  • alveolar type 1 fibroblast cell CL4028004
    CSI 3.26
    rCSI 3.57%
    PRS 74.24
  • naive T cell CL0000898
    CSI 3.24
    rCSI 2.26%
    PRS 85.6
  • CD4-positive helper T cell CL0000492
    CSI 3.15
    rCSI 2.39%
    PRS 84.31
  • monocyte CL0000576
    CSI 3.12
    rCSI 5.64%
    PRS 80.69
  • alpha-beta T cell CL0000789
    CSI 3.11
    rCSI 3.64%
    PRS 85.96
  • group 3 innate lymphoid cell CL0001071
    CSI 3.11
    rCSI 2.33%
    PRS 77.03
  • conventional dendritic cell CL0000990
    CSI 3.05
    rCSI 2.54%
    PRS 76.51
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 3.03
    rCSI 15.2%
    PRS 83.56
  • stem cell CL0000034
    CSI 2.98
    rCSI 2.88%
    PRS 62.89
  • activated type II NK T cell CL0000931
    CSI 2.94
    rCSI 3.3%
    PRS 86.03
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.87
    rCSI 4.58%
    PRS 75.29
  • mature T cell CL0002419
    CSI 2.84
    rCSI 2.21%
    PRS 87.08
  • mucus secreting cell CL0000319
    CSI 2.84
    rCSI 4.51%
    PRS 81.23
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 2.84
    rCSI 2.04%
    PRS 84.52
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.76
    rCSI 2.14%
    PRS 74.47
  • vascular associated smooth muscle cell CL0000359
    CSI 2.71
    rCSI 8.77%
    PRS 70.31
  • interstitial cell of Cajal CL0002088
    CSI 2.65
    rCSI 3.38%
    PRS 76.97
  • glioblast CL0000030
    CSI 2.6
    rCSI 4.15%
    PRS 62.82
  • T follicular helper cell CL0002038
    CSI 2.6
    rCSI 1.95%
    PRS 85.1
  • pulmonary capillary endothelial cell CL4028001
    CSI 2.6
    rCSI 4.96%
    PRS 83.45
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.6
    rCSI 2.25%
    PRS 75.85
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 2.58
    rCSI 2.33%
    PRS 68.43
  • intestine goblet cell CL0019031
    CSI 2.49
    rCSI 2.21%
    PRS 68.99
  • lung macrophage CL1001603
    CSI 2.43
    rCSI 5.43%
    PRS 79.17
  • blood vessel smooth muscle cell CL0019018
    CSI 2.41
    rCSI 19.63%
    PRS 64.62
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.4
    rCSI 1.62%
    PRS 84.27
  • peripheral nervous system neuron CL2000032
    CSI 2.4
    rCSI 3.27%
    PRS 62.46
  • natural T-regulatory cell CL0000903
    CSI 2.4
    rCSI 4.54%
    PRS 93.52
  • lung ciliated cell CL1000271
    CSI 2.36
    rCSI 2.73%
    PRS 62.16
  • alternatively activated macrophage CL0000890
    CSI 2.35
    rCSI 2.95%
    PRS 82.22
  • hematopoietic stem cell CL0000037
    CSI 2.31
    rCSI 1.53%
    PRS 74.03
  • common dendritic progenitor CL0001029
    CSI 2.3
    rCSI 2.88%
    PRS 81.03
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.29
    rCSI 3.58%
    PRS 90.62
  • keratinocyte CL0000312
    CSI 2.24
    rCSI 1.88%
    PRS 74.6
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 2.23
    rCSI 2.19%
    PRS 87.89
  • immature B cell CL0000816
    CSI 2.21
    rCSI 1.64%
    PRS 83.59
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.2
    rCSI 3.02%
    PRS 88.56
  • common myeloid progenitor CL0000049
    CSI 2.18
    rCSI 1.76%
    PRS 73.09
  • respiratory hillock cell CL4030023
    CSI 2.16
    rCSI 3.84%
    PRS 82.55
  • myeloid leukocyte CL0000766
    CSI 2.08
    rCSI 1.92%
    PRS 72.95
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.04
    rCSI 1.57%
    PRS 73.09
  • Langerhans cell CL0000453
    CSI 2.01
    rCSI 3.07%
    PRS 84.96
  • adventitial cell CL0002503
    CSI 1.99
    rCSI 4.75%
    PRS 77.65
  • common lymphoid progenitor CL0000051
    CSI 1.99
    rCSI 2.65%
    PRS 88.59
  • respiratory suprabasal cell CL4033048
    CSI 1.97
    rCSI 2.53%
    PRS 75.4
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 1.95
    rCSI 1.98%
    PRS 82.42
  • nasal mucosa goblet cell CL0002480
    CSI 1.93
    rCSI 2.24%
    PRS 77.13
  • colon epithelial cell CL0011108
    CSI 1.93
    rCSI 2.02%
    PRS 68.14
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 1.93
    rCSI 2.47%
    PRS 67.61
  • cerebral cortex endothelial cell CL1001602
    CSI 1.91
    rCSI 3.31%
    PRS 61.6
  • alveolar adventitial fibroblast CL4028006
    CSI 1.85
    rCSI 2.92%
    PRS 73.17
  • colonocyte CL1000347
    CSI 1.83
    rCSI 2.62%
    PRS 73.25
  • club cell CL0000158
    CSI 1.82
    rCSI 2.67%
    PRS 65.99
  • tracheobronchial serous cell CL0019001
    CSI 1.82
    rCSI 7.87%
    PRS 81.28
  • neural crest cell CL0011012
    CSI 1.82
    rCSI 1.44%
    PRS 58.42
  • radial glial cell CL0000681
    CSI 1.82
    rCSI 2.53%
    PRS 69.55
  • plasmablast CL0000980
    CSI 1.82
    rCSI 1.43%
    PRS 77.67
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.79
    rCSI 2.14%
    PRS 88.12
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 0.9%
    PRS 78.1%
  • hair follicular keratinocyte CL2000092
    CSI 0.3
    rCSI 4.8%
    PRS 86.2%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.3
    rCSI 4.3%
    PRS 83.6%
  • kidney interstitial cell CL1000500
    CSI 0.4
    rCSI 6.7%
    PRS 79.4%
  • keratocyte CL0002363
    CSI 0.7
    rCSI 1.7%
    PRS 76.8%
  • forebrain radial glial cell CL0013000
    CSI 0.7
    rCSI 2.3%
    PRS 74.6%
  • vasa recta ascending limb cell CL1001131
    CSI 0.8
    rCSI 3.6%
    PRS 83.0%
  • epithelial cell of esophagus CL0002252
    CSI 0.9
    rCSI 9.1%
    PRS 82.0%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.9
    rCSI 6.4%
    PRS 81.2%
  • transitional stage B cell CL0000818
    CSI 1.0
    rCSI 3.2%
    PRS 90.8%
  • BEST4+ enteroycte CL4030026
    CSI 1.0
    rCSI 1.2%
    PRS 72.8%
  • mesenchymal cell CL0008019
    CSI 1.1
    rCSI 2.8%
    PRS 64.8%
  • dendritic cell, human CL0001056
    CSI 1.1
    rCSI 1.8%
    PRS 80.5%
  • stromal cell of ovary CL0002132
    CSI 1.2
    rCSI 3.2%
    PRS 80.9%
  • lung secretory cell CL1000272
    CSI 1.2
    rCSI 3.0%
    PRS 70.0%
  • extravillous trophoblast CL0008036
    CSI 1.4
    rCSI 1.7%
    PRS 68.2%
  • mesodermal cell CL0000222
    CSI 1.4
    rCSI 1.7%
    PRS 69.3%
  • stromal cell CL0000499
    CSI 1.4
    rCSI 4.1%
    PRS 66.8%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 1.5
    rCSI 1.8%
    PRS 54.4%
  • promonocyte CL0000559
    CSI 1.5
    rCSI 2.5%
    PRS 78.9%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.5
    rCSI 1.8%
    PRS 80.1%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.5
    rCSI 3.7%
    PRS 64.2%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 1.5
    rCSI 2.7%
    PRS 78.1%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.6
    rCSI 1.1%
    PRS 74.2%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.6
    rCSI 2.7%
    PRS 86.2%
  • tendon cell CL0000388
    CSI 1.6
    rCSI 4.3%
    PRS 82.0%
  • duct epithelial cell CL0000068
    CSI 1.7
    rCSI 2.5%
    PRS 76.1%
  • muscle cell CL0000187
    CSI 1.7
    rCSI 3.6%
    PRS 85.3%
  • mesenchymal stem cell CL0000134
    CSI 1.8
    rCSI 19.1%
    PRS 80.2%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.8
    rCSI 2.1%
    PRS 88.1%
  • plasmablast CL0000980
    CSI 1.8
    rCSI 1.4%
    PRS 77.7%
  • radial glial cell CL0000681
    CSI 1.8
    rCSI 2.5%
    PRS 69.6%
  • neural crest cell CL0011012
    CSI 1.8
    rCSI 1.4%
    PRS 58.4%
  • tracheobronchial serous cell CL0019001
    CSI 1.8
    rCSI 7.9%
    PRS 81.3%
  • club cell CL0000158
    CSI 1.8
    rCSI 2.7%
    PRS 66.0%
  • colonocyte CL1000347
    CSI 1.8
    rCSI 2.6%
    PRS 73.3%
  • alveolar adventitial fibroblast CL4028006
    CSI 1.9
    rCSI 2.9%
    PRS 73.2%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.9
    rCSI 3.3%
    PRS 61.6%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 1.9
    rCSI 2.5%
    PRS 67.6%
  • colon epithelial cell CL0011108
    CSI 1.9
    rCSI 2.0%
    PRS 68.1%
  • nasal mucosa goblet cell CL0002480
    CSI 1.9
    rCSI 2.2%
    PRS 77.1%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.0
    rCSI 2.0%
    PRS 82.4%
  • respiratory suprabasal cell CL4033048
    CSI 2.0
    rCSI 2.5%
    PRS 75.4%
  • common lymphoid progenitor CL0000051
    CSI 2.0
    rCSI 2.7%
    PRS 88.6%
  • adventitial cell CL0002503
    CSI 2.0
    rCSI 4.8%
    PRS 77.7%
  • Langerhans cell CL0000453
    CSI 2.0
    rCSI 3.1%
    PRS 85.0%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.0
    rCSI 1.6%
    PRS 73.1%
  • myeloid leukocyte CL0000766
    CSI 2.1
    rCSI 1.9%
    PRS 73.0%
  • respiratory hillock cell CL4030023
    CSI 2.2
    rCSI 3.8%
    PRS 82.6%
  • common myeloid progenitor CL0000049
    CSI 2.2
    rCSI 1.8%
    PRS 73.1%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 2.2
    rCSI 3.0%
    PRS 88.6%
  • immature B cell CL0000816
    CSI 2.2
    rCSI 1.6%
    PRS 83.6%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 2.2
    rCSI 2.2%
    PRS 87.9%
  • keratinocyte CL0000312
    CSI 2.2
    rCSI 1.9%
    PRS 74.6%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.3
    rCSI 3.6%
    PRS 90.6%
  • common dendritic progenitor CL0001029
    CSI 2.3
    rCSI 2.9%
    PRS 81.0%
  • hematopoietic stem cell CL0000037
    CSI 2.3
    rCSI 1.5%
    PRS 74.0%
  • alternatively activated macrophage CL0000890
    CSI 2.4
    rCSI 3.0%
    PRS 82.2%
  • lung ciliated cell CL1000271
    CSI 2.4
    rCSI 2.7%
    PRS 62.2%
  • natural T-regulatory cell CL0000903
    CSI 2.4
    rCSI 4.5%
    PRS 93.5%
  • peripheral nervous system neuron CL2000032
    CSI 2.4
    rCSI 3.3%
    PRS 62.5%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.4
    rCSI 1.6%
    PRS 84.3%
  • blood vessel smooth muscle cell CL0019018
    CSI 2.4
    rCSI 19.6%
    PRS 64.6%
  • lung macrophage CL1001603
    CSI 2.4
    rCSI 5.4%
    PRS 79.2%
  • intestine goblet cell CL0019031
    CSI 2.5
    rCSI 2.2%
    PRS 69.0%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 2.6
    rCSI 2.3%
    PRS 68.4%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.6
    rCSI 2.3%
    PRS 75.9%
  • pulmonary capillary endothelial cell CL4028001
    CSI 2.6
    rCSI 5.0%
    PRS 83.5%
  • T follicular helper cell CL0002038
    CSI 2.6
    rCSI 2.0%
    PRS 85.1%
  • glioblast CL0000030
    CSI 2.6
    rCSI 4.2%
    PRS 62.8%
  • interstitial cell of Cajal CL0002088
    CSI 2.7
    rCSI 3.4%
    PRS 77.0%
  • vascular associated smooth muscle cell CL0000359
    CSI 2.7
    rCSI 8.8%
    PRS 70.3%
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.8
    rCSI 2.1%
    PRS 74.5%
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 2.8
    rCSI 2.0%
    PRS 84.5%
  • mucus secreting cell CL0000319
    CSI 2.8
    rCSI 4.5%
    PRS 81.2%
  • mature T cell CL0002419
    CSI 2.8
    rCSI 2.2%
    PRS 87.1%
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.9
    rCSI 4.6%
    PRS 75.3%
  • activated type II NK T cell CL0000931
    CSI 2.9
    rCSI 3.3%
    PRS 86.0%
  • stem cell CL0000034
    CSI 3.0
    rCSI 2.9%
    PRS 62.9%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 3.0
    rCSI 15.2%
    PRS 83.6%
  • conventional dendritic cell CL0000990
    CSI 3.1
    rCSI 2.5%
    PRS 76.5%
  • group 3 innate lymphoid cell CL0001071
    CSI 3.1
    rCSI 2.3%
    PRS 77.0%
  • alpha-beta T cell CL0000789
    CSI 3.1
    rCSI 3.6%
    PRS 86.0%
  • monocyte CL0000576
    CSI 3.1
    rCSI 5.6%
    PRS 80.7%
  • CD4-positive helper T cell CL0000492
    CSI 3.2
    rCSI 2.4%
    PRS 84.3%
  • naive T cell CL0000898
    CSI 3.2
    rCSI 2.3%
    PRS 85.6%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 3.3
    rCSI 3.6%
    PRS 74.2%
  • precursor B cell CL0000817
    CSI 3.6
    rCSI 3.2%
    PRS 79.6%
  • enterocyte CL0000584
    CSI 3.7
    rCSI 5.9%
    PRS 72.4%
  • myofibroblast cell CL0000186
    CSI 3.8
    rCSI 5.2%
    PRS 70.3%
  • fibroblast of breast CL4006000
    CSI 3.8
    rCSI 16.0%
    PRS 79.9%
  • pulmonary alveolar type 1 cell CL0002062
    CSI 4.0
    rCSI 22.8%
    PRS 68.9%
  • pro-B cell CL0000826
    CSI 4.0
    rCSI 3.3%
    PRS 73.5%
  • smooth muscle cell CL0000192
    CSI 4.1
    rCSI 9.7%
    PRS 71.1%
  • CD14-positive monocyte CL0001054
    CSI 4.3
    rCSI 5.3%
    PRS 81.6%
  • non-classical monocyte CL0000875
    CSI 4.3
    rCSI 7.0%
    PRS 87.0%
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 4.5
    rCSI 3.6%
    PRS 88.0%
  • double negative thymocyte CL0002489
    CSI 4.6
    rCSI 3.2%
    PRS 82.6%
  • T-helper 17 cell CL0000899
    CSI 4.7
    rCSI 3.7%
    PRS 90.0%
  • blood vessel endothelial cell CL0000071
    CSI 4.7
    rCSI 9.8%
    PRS 68.1%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [PDLIM2](/details-gene/64236) (PDZ and LIM domain 2) is a protein-coding gene located on chromosome 8p21.3. It encodes a scaffolding protein that plays a crucial role in cytoskeletal organization and cell adhesion. Functionally, [PDLIM2](/details-gene/64236) is involved in linking actin filaments to cellular junctions and is implicated in processes such as actin cytoskeleton organization ([GO:0030036](https://www.ebi.ac.uk/QuickGO/term/GO:0030036)), muscle structure development ([GO:0061061](https://www.ebi.ac.uk/QuickGO/term/GO:0061061)), and protein degradation pathways through its interaction with ubiquitin ligases. Its expression profile indicates a significant role in structurally active tissues, with high significance observed in cell types such as [intestinal epithelial cell](/details-cell/CL0002563), [skin fibroblast](/details-cell/CL0002620), and various smooth muscle and endothelial cells. ## Cellular Roles and Expression Landscape **Overall**, the expression pattern of [PDLIM2](/details-gene/64236) highlights its importance as a structural and signaling component in a variety of cell types essential for tissue architecture and integrity. The gene shows its highest significance in [intestinal epithelial cell](/details-cell/CL0002563) (CSI: 27.30), suggesting a primary function in maintaining the structure and integrity of the intestinal barrier. This is complemented by high significance in other stromal and structural cells, including [skin fibroblast](/details-cell/CL0002620) (CSI: 20.16), [microcirculation associated smooth muscle cell](/details-cell/CL0008035) (CSI: 15.98), and [perivascular cell](/details-cell/CL4033054) (CSI: 12.69). This broad expression in fibroblasts and muscle cells points to a conserved role in managing cytoskeletal tension and adhesion across different tissues. Furthermore, [PDLIM2](/details-gene/64236) is notably significant in specialized epithelial and endothelial lineages, such as [syncytiotrophoblast cell](/details-cell/CL0000525) (CSI: 15.92) in the placenta, [podocyte](/details-cell/CL0000653) (CSI: 11.81) in the kidney, and [endothelial cell of lymphatic vessel](/details-cell/CL0002138) (CSI: 13.45). Its presence in these cells underscores its role in specialized cell junctions and filtration barriers. While primarily a structural protein, [PDLIM2](/details-gene/64236) also shows moderate significance in immune cells like the [mononuclear phagocyte](/details-cell/CL0000113) (CSI: 10.58) and [mature B cell](/details-cell/CL0000785) (CSI: 8.05), which may relate to its involvement in cell migration and signaling, as suggested by phosphoproteomic studies in T cells ([Link](https://doi.org/10.1126/scisignal.2000007)). ## Pathways and Molecular Function The functions of [PDLIM2](/details-gene/64236) are intrinsically linked to its role as a molecular scaffold at the cytoskeleton. Its involvement in **Biological Processes** such as actin cytoskeleton organization ([GO:0030036](https://www.ebi.ac.uk/QuickGO/term/GO:0030036)) and muscle development ([GO:0061061](https://www.ebi.ac.uk/QuickGO/term/GO:0061061)) is directly supported by its **Molecular Functions**, which include binding to key structural proteins like actin ([GO:0003779](https://www.ebi.ac.uk/QuickGO/term/GO:0003779)), filamin ([GO:0031005](https://www.ebi.ac.uk/QuickGO/term/GO:0031005)), and muscle alpha-actinin ([GO:0051371](https://www.ebi.ac.uk/QuickGO/term/GO:0051371)). Its localization to critical **Cellular Components** such as the [Z disc](/details-cell/GO:0030018) in muscle, [adherens junction](/details-cell/GO:0005912) in epithelial cells, and [stress fiber](/details-cell/GO:0001725) in fibroblasts provides a physical basis for its high expression in these respective cell types. In addition to its structural role, [PDLIM2](/details-gene/64236) is associated with the protein catabolic process ([GO:0030163](https://www.ebi.ac.uk/QuickGO/term/GO:0030163)) through its ability to bind ubiquitin protein ligases ([GO:0031625](https://www.ebi.ac.uk/QuickGO/term/GO:0031625)), suggesting it may participate in the targeted degradation of proteins at cytoskeletal anchorage sites, thereby regulating cell adhesion and signaling dynamics. Studies have also shown it promotes cell attachment and migration ([Link](https://doi.org/10.1091/mbc.e04-12-1052)). ## Research Directions The widespread expression of [PDLIM2](/details-gene/64236) in structural cells, combined with its dual function in cytoskeletal organization and protein turnover, suggests it may be a key player in tissue remodeling during both physiological and pathological processes. ### Testable Hypotheses 1. **Role in Intestinal Barrier Dysfunction:** Given its top significance in [intestinal epithelial cell](/details-cell/CL0002563) and its localization to [adherens junction](/details-cell/GO:0005912), we hypothesize that downregulation or dysfunction of [PDLIM2](/details-gene/64236) under inflammatory conditions (e.g., in Inflammatory Bowel Disease) compromises epithelial barrier integrity, leading to increased permeability and perpetuation of inflammation. 2. **Involvement in Tissue Fibrosis:** The high significance of [PDLIM2](/details-gene/64236) in various fibroblast populations ([skin fibroblast](/details-cell/CL0002620), [fibroblast of lung](/details-cell/CL0002553)) and its function in organizing stress fibers suggests a role in fibroblast activation. We hypothesize that [PDLIM2](/details-gene/64236) expression is upregulated during fibrotic processes, where it facilitates the transition of fibroblasts into contractile myofibroblasts, thereby driving extracellular matrix deposition and tissue stiffening. 3. **Function in Cancer Cell Migration:** Previous research indicates [PDLIM2](/details-gene/64236) can promote cell migration and suppress anchorage-independent growth ([Link](https://doi.org/10.1091/mbc.e04-12-1052)). We hypothesize that its expression level in tumor-associated fibroblasts or in cancer cells themselves modulates the invasive potential of solid tumors by remodeling the actin cytoskeleton to facilitate migration. ### Proposed Experiment To test the hypothesis regarding its role in tissue fibrosis (Hypothesis 2), a robust *in vitro* model could be employed. Primary human lung fibroblasts could be cultured and stimulated with TGF-β1 to induce myofibroblast differentiation. [PDLIM2](/details-gene/64236) expression would be silenced using CRISPR-Cas9 or siRNA. The experimental readouts would include quantitative PCR and Western blotting for fibrotic markers (e.g., α-SMA, collagen type I), immunofluorescence to assess stress fiber formation, and a collagen gel contraction assay to measure cellular contractility. This experiment would clarify whether [PDLIM2](/details-gene/64236) is a necessary component for the pro-fibrotic response in fibroblasts. ### Therapeutic Potential As an intracellular scaffolding protein, [PDLIM2](/details-gene/64236) presents a challenging target for traditional antibody-based therapies. However, if its role in pathologies like fibrosis or cancer metastasis is confirmed, it could be a target for small molecule inhibitors designed to disrupt its key protein-protein interactions (e.g., its binding to actin or α-actinin). Given its pro-migratory and pro-fibrotic potential, a therapeutic strategy would likely focus on **inhibition** rather than activation. The development of such inhibitors would be complex but could offer a novel approach to treating diseases characterized by excessive tissue remodeling and cell migration.

Genular Protein ID: 2925858767

Symbol: PDLI2_HUMAN

Name: PDZ and LIM domain protein 2

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 15498874

Title: Large-scale cDNA transfection screening for genes related to cancer development and progression.

PubMed ID: 15498874

DOI: 10.1073/pnas.0404089101

PubMed ID: 11214971

Title: Characterization of long cDNA clones from human adult spleen.

PubMed ID: 11214971

DOI: 10.1093/dnares/7.6.357

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16421571

Title: DNA sequence and analysis of human chromosome 8.

PubMed ID: 16421571

DOI: 10.1038/nature04406

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 15659642

Title: Mystique is a new IGF-I regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses anchorage independent growth.

PubMed ID: 15659642

DOI: 10.1091/mbc.e04-12-1052

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

Sequence Information:

  • Length: 352
  • Mass: 37459
  • Checksum: E36EC66C61C5E9DB
  • Sequence:
  • MALTVDVAGP APWGFRITGG RDFHTPIMVT KVAERGKAKD ADLRPGDIIV AINGESAEGM 
    LHAEAQSKIR QSPSPLRLQL DRSQATSPGQ TNGDSSLEVL ATRFQGSVRT YTESQSSLRS 
    SYSSPTSLSP RAGSPFSPPP SSSSLTGEAA ISRSFQSLAC SPGLPAADRL SYSGRPGSRQ 
    AGLGRAGDSA VLVLPPSPGP RSSRPSMDSE GGSLLLDEDS EVFKMLQENR EGRAAPRQSS 
    SFRLLQEALE AEERGGTPAF LPSSLSPQSS LPASRALATP PKLHTCEKCS TSIANQAVRI 
    QEGRYRHPGC YTCADCGLNL KMRGHFWVGD ELYCEKHARQ RYSAPATLSS RA